Faculty

Christoph Correll

MD
Professor of Psychiatry
Zucker School of Medicine at Hofstra/Northwell

Christoph Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital, NY. Since 1997, he has been working in New York, USA, and since 2017 he is also working in Germany again.

Dr. Correll focuses on the early identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-analyses, and physical health in mental health. He has published over 1000 journal articles that have been cited more than 94.000 times, and in 05/2025, his h-index was 153, being >100 in the last 5 years alone. He has received over 40 research awards. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”. Additionally, he has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, including in 05/2025 being ranked number one among world experts in 9 areas, including “central nervous system agents”, “psychotropic drugs“, “schizophrenia”, “schizophrenia spectrum/other psychotic disorders”, “antipsychotics”, “delayed action preparations” and “weight gain”.

2026 Sessions

MasterClass: Presynaptic Possibilities: The Past, Present, and Future of Modulating Dopamine

As our understanding of dopamine regulation evolves, new therapeutic strategies are expanding beyond traditional postsynaptic targets. This session examines the neurobiology of presynaptic dopamine modulation across schizophrenia and bipolar I mania, reviews emerging evidence for selective muscarinic agents, and provides practical guidance for applying these developments to individualized patient care.<br><br>Supported by an educational grant from Bristol-Myers Squibb.

Speaker

Tuesday, September 15 4:45–6:15 PM
Room Great Hall D
Faculty

Christoph Correll

MD
Professor of Psychiatry
Zucker School of Medicine at Hofstra/Northwell

Christoph Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital, NY. Since 1997, he has been working in New York, USA, and since 2017 he is also working in Germany again.

Dr. Correll focuses on the early identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-analyses, and physical health in mental health. He has published over 1000 journal articles that have been cited more than 94.000 times, and in 05/2025, his h-index was 153, being >100 in the last 5 years alone. He has received over 40 research awards. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”. Additionally, he has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, including in 05/2025 being ranked number one among world experts in 9 areas, including “central nervous system agents”, “psychotropic drugs“, “schizophrenia”, “schizophrenia spectrum/other psychotic disorders”, “antipsychotics”, “delayed action preparations” and “weight gain”.

Steering Committee

Chelsie Monroe

MSN, APN, PMHNP-BC
Founder
Balanced Mental Wellness

Chelsie Monroe is a board-certified Psychiatric Mental Health Nurse Practitioner and founder of a group private practice, Balanced Mental Wellness in Littleton, Colorado where she serves as medical director. She has over 15 years of experience working in a variety of settings including inpatient, outpatient, psychiatric emergency services, forensics, community mental health, and private practice settings. She specializes in complex trauma, forensics, addiction, and severe mental illnesses, and has special interest in psychedelic assisted therapies and entrepreneurial APN roles. Chelsie is board certified in Integrative Psychiatry, and is an expert in ketamine assisted psychotherapy (KAP). She is trained as a psychotherapist and believes the relationship is the key to being an excellent clinician.

MasterClass: The Road to Recovery in MDD: From Partial Response to Remission and Beyond

Many patients with MDD experience only partial improvement despite adequate antidepressant therapy. This session focuses on recognizing clinically meaningful residual symptoms, reviews emerging evidence for adjunctive pharmacologic options, and provides practical approaches to optimizing treatment with the goal of achieving remission and sustained recovery.<br><br>Supported by an educational grant from Johnson & Johnson.

Speaker

Wednesday, September 16 2:45–4:15 PM
Room Great Hall D
Faculty

Christoph Correll

MD
Professor of Psychiatry
Zucker School of Medicine at Hofstra/Northwell

Christoph Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital, NY. Since 1997, he has been working in New York, USA, and since 2017 he is also working in Germany again.

Dr. Correll focuses on the early identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-analyses, and physical health in mental health. He has published over 1000 journal articles that have been cited more than 94.000 times, and in 05/2025, his h-index was 153, being >100 in the last 5 years alone. He has received over 40 research awards. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”. Additionally, he has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, including in 05/2025 being ranked number one among world experts in 9 areas, including “central nervous system agents”, “psychotropic drugs“, “schizophrenia”, “schizophrenia spectrum/other psychotic disorders”, “antipsychotics”, “delayed action preparations” and “weight gain”.

Steering Committee

Brooke Kempf

PMHNP-BC
Adjunct Faculty
Indiana University Indianapolis

Brooke Kempf, PMHNP-BC, is a nationally recognized psychiatric-mental health nurse practitioner and educator with nearly three decades of experience providing direct patient care and advancing evidence-based mental health services.
She began her career at Hamilton Center in Terre Haute, Indiana, where she worked as a psychiatric nurse across multiple areas of the community mental health center. Her leadership earned her the Hamilton Award for Outstanding Staff Member and helped shape an outpatient care model now used across several sites.
Brooke earned her Master of Science in Nursing from Stony Brook University and is board-certified as a Psychiatric-Mental Health Nurse Practitioner through the American Nurses Credentialing Center. Her advanced certification expanded her clinical role to include medication management and psychiatric care as an outpatient provider, inpatient hospitalist, and Chief Nursing Officer. She also played a key role in integrating psychiatric services into Wabash Valley Health Center, expanding access to care for underserved communities.
In addition to her clinical and administrative leadership, Brooke serves as adjunct faculty in the PMHNP program at Indiana University Indianapolis, where she has taught Neuro-Psychopharmacology and serves as a clinical instructor. She has contributed to program development at George Washington University and received the DAISY Award for Extraordinary Nursing Faculty. Nationally, she serves on pharmaceutical advisory boards, the Psych Congress Steering Committee, and volunteers with the American Foundation for Suicide Prevention.

Latest Discoveries & Emerging Trends in Psychotic Disorders

Breakthrough research in schizophrenia and other psychotic disorders is shaping the future of treatment, diagnosis, and prevention. This session will provide a fast-paced, research-focused deep dive into the most significant discoveries of the past year, featuring expert analysis alongside selected poster presenters unveiling emerging data. Faculty will discuss the latest advancements, offering insight into how these findings may change the way clinicians approach psychotic disorders.

Speaker

Wednesday, September 16 4:30–5:30 PM
Room Great Hall A
Latest Discoveries & Emerging Trends
Faculty

Christoph Correll

MD
Professor of Psychiatry
Zucker School of Medicine at Hofstra/Northwell

Christoph Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital, NY. Since 1997, he has been working in New York, USA, and since 2017 he is also working in Germany again.

Dr. Correll focuses on the early identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-analyses, and physical health in mental health. He has published over 1000 journal articles that have been cited more than 94.000 times, and in 05/2025, his h-index was 153, being >100 in the last 5 years alone. He has received over 40 research awards. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”. Additionally, he has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, including in 05/2025 being ranked number one among world experts in 9 areas, including “central nervous system agents”, “psychotropic drugs“, “schizophrenia”, “schizophrenia spectrum/other psychotic disorders”, “antipsychotics”, “delayed action preparations” and “weight gain”.

Steering Committee

Ilan Melnick

MD
Chief Medical Officer, Passageway Residences of Dade County,
Passageway Residences of Dade County

Ilan Melnick, MD, is the primary psychiatrist in two outpatient clinics in the Miami, Florida area, as well as a staff psychiatrist and Chief Medical Officer at Passageway Residences of Miami-Dade County. In addition, Dr. Melnick is a staff psychiatrist and Medical Director for Jewish Community Services and performs independent medical and psychiatric evaluations for Miami-Dade County police, fire, transit and aviation departments.

Dr. Melnick received his medical degree in Bayamon, Puerto Rico and went on to do his residency in psychiatry and fellowship in geriatric psychiatry at the University of Miami/Jackson Memorial Hospital.He continues to be involved in education as an Assistant Professor at Florida International University School of medicine. He continues to be involved in education through his role giving grand rounds at major universities and hospitals around the world.

Back to top